2 penny stocks with enormous potential

Edward Sheldon has been scanning the market for penny stocks with a lot of potential. And he believes these two are worth a look.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Penny stocks can have a place in a well-diversified portfolio. They’re higher risk, but the returns can be explosive.

Here, I’m going to highlight two top penny stocks on the London Stock Exchange. In my view, these shares have bags of potential.

In a strong position

First up is hVIVO (LSE: HVO).

It’s a small healthcare company that offers services for clinical trials and lab testing. Playing a vital role in the pharma industry, it serves several of the world’s largest global biopharmaceutical companies.

A recent trading update from hVIVO was very positive.

For starters, the company said that right now, it’s in its “strongest ever position” with 90% of 2024 revenue guidance already contracted, and record revenue visibility into 2025. For 2024, it expects to achieve revenue of £62m (+11% year on year)

Secondly, it advised that it’s on schedule to open a new state-of-the-art facility in Canary Wharf, London, in the first half of the 2024. This will enable the company to meet the growing demand for human challenge trials and allow it to further scale up. By 2028, it is hoping to be generating revenues of £100m per year.

I am excited about 2024 as we look forward to our move to a larger facility and the further diversification of our services.

Dr Yamin ‘Mo’ Khan, CEO of hVIVO

At present, hVIVO shares trade on a forward-looking price-to-earnings (P/E) ratio of around 23. This above-average valuation does add some risk.

Given the strong growth the company is generating right now, however, I think the overall risk/reward skew is attractive.

Taking a long-term view, I think the stock is likely to move higher.

Unlocking new opportunities

The other penny stock I want to highlight is Netcall (LSE: NET).

It’s a technology company that specialises in artificial intelligence-powered process automation and customer engagement software. Its customers include Legal & General, Nationwide, and the NHS.

This company has a great growth track record. Over the last five years, its revenue has grown from £21.9m to £36m (+64%) as organisations have embraced its automation solutions. And looking ahead, analysts expect the top-line growth to continue with a figure of £39.1m forecast for the year ending 30 June 2024 and £43.4m estimated for the following year.

It’s worth noting that management was quite bullish in a recent trading update. “We remain well positioned as we enter the second half, with our innovative product roadmap continuing to unlock new opportunities in a structurally-growing market,” said CEO James Ormondroyd.

Now, this stock has a higher valuation too. Currently, the forward-looking P/E ratio here is about 31.

I don’t think that’s unreasonable given that the technology company is growing rapidly and has a lot of recurring revenues.

But it does add some risk to the investment case. If growth slows, the stock could be volatile.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has positions in London Stock Exchange Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Google office headquarters
Investing Articles

1 reason I like buying S&P 500 shares – and 1 reason I don’t

Will this investor try to improve his potential returns by focusing more on S&P 500 shares instead of British ones?…

Read more »

Young woman holding up three fingers
Investing Articles

3 SIPP mistakes to avoid

Our writer explains a trio of potentially costly errors he tries to avoid making when investing his SIPP, on an…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how (and why) I’d start buying shares with £25 a week

Our writer uses his investment experience and current approach to explain how he would start buying shares on a limited…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s my 5-step approach to earning passive income of £500 a month

Christopher Ruane explains the handful of steps he uses to target hundreds of pounds in passive income each month.

Read more »

Investing Articles

2 UK shares I’ve been buying this week

From a value perspective, UK shares look attractive. But two in particular have been attracting Stephen Wright’s attention over the…

Read more »

Investing Articles

A lifelong second income for just £10 a week? Here’s how!

With a simple, structured approach to buying blue-chip dividend shares at attractive prices, our writer's building a second income for…

Read more »

Investing Articles

Here’s how I’d use a £20k Stocks and Shares ISA to help build generational wealth

Discover how our writer would aim to turn a £20k Stocks and Shares ISA into a sizeable nest egg by…

Read more »